The global flow cytometry market is expected to reach $3.7 billion by 2018, at a CAGR of 10% from 2013 to 2018. Increasing applications of technological advancements in flow cytometry instruments, fostering research activities in the field of life sciences, growing clinical trials, fostering prevalence of HIV and cancer, launch of new reagents for specific applications such as diagnostics, drug discovery and development of user friendly and intuitive software’s are driving the growth of the flow cytometry market
Geographically, the global flow cytometry market is divided into four regions, namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America and a major part of the European region are saturated markets for this product. North America accounted for the largest share of the global market in 2013. This growth is attributed to a number of factors such as presence of flow cytometry associations in this region, increasing use of flow cytometry techniques in cancer research, rise in investment initiatives by the government, and high quality infrastructure for clinical and laboratory research.
Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=65374584
On the basis of the type of technology, the flow cytometry market is segmented into cell-based, bead-based, and others. The cell-based flow cytometry segment accounted for the largest share of the global market in 2013. This is mainly because cell-based assays encompass the benefits of testing the compounds activity against molecular targets within the context of living cells; thus it is increasingly used in drug discovery processes. However, bead based flow cytometry is expected to grow at a higher rate as compared to the cell based ones because of decreased system cost, better statistical performance, and enhanced hybridization kinetics.
On the basis of products, the global flow cytometry market has been segmented into instruments, reagents and consumables, software, services, and accessories. In 2013, the reagents and consumables segment accounted for the largest share of 45%in the global market, and is also expected to grow at the highest CAGR of 11.2% from 2013 to 2018. In addition, the global market is classified into three segments based on the type of technology, namely, cell-based, bead-based, and others. The cell-based segment accounted for the largest share of 80% in the global market
Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=65374584
The emerging markets including China and India are becoming attractive for the companies engaged in the development and marketing of the products. Various economic developments and growing prevalence of HIV/AIDS, growing number of research initiatives, increasing government support, and growing focus of both international and domestic players are the key factors propelling the demand for flow cytometry products in the Asia-Pacific region.
The flow cytometry market is a diversified and competitive market. The key players in this market are Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), eBioscience, Inc. (U.S.), EMD Millipore Corporation (U.S.), Life Technologies Corporation (U.S.), Luminex Corporation (U.S.), Miltenyi Biotec (Germany), and Partec GmbH (Germany).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets